Can science prevail against this more turbulent backdrop of the Trump administration? Yahoo Finance executive editor Brian Sozzi talks at length with Novartis CEO Vas Narasimhan. Narasimhan has led the drug giant since 2018, doing deals that have expanded the company’s pipeline in areas like heart disease and cancer. Still, Narasimhan is feeling pressure to ... Show More
Oct 15
Sylvester Stallone: Corporate studios killed the "classic movie"
Yahoo Finance Executive Editor Brian Sozzi talks with legendary actor Sylvester Stallone about the shifting economics of Hollywood, why studios refuse to take risks on original ideas, and why streaming is now the only place to find premium, award-worthy drama. Learn more about yo ... Show More
21m 8s
Jun 2025
Novartis CEO: Medical Innovation, Tech Partnerships, and European Competitiveness
Can AI help us find cures for diseases we've never been able to treat? Nicolai Tangen speaks with Vasant 'Vas' Narasimhan, CEO of Novartis, about pioneering pharmaceutical innovation. They explore breakthrough cell and gene therapies, AI partnerships with leading tech companies, ... Show More
46m 34s
Nov 2024
Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges
<p>What’s next for cancer treatment and personalized medicine? How is AI reshaping the future of drug discovery? And can Europe keep pace with China’s rapid rise in health care innovation? In this episode, Nicolai welcomes Thomas Schinecker, CEO of Roche, one of the world’s large ... Show More
53m 58s
Apr 2024
301: Biotech mega-rounds, a cancer vaccine setback & CEOs keep their promise
Oruka Therapeutics CEO Lawrence Klein joins us to discuss how his company raised its first round of financing before competing with major players in the inflammation space. We also discuss the latest news in the life sciences, including the end of the Amylyx ALS saga, another use ... Show More
31m 37s